Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-25 4:24 pm Sale | 2021-05-20 | 13D | Innoviva, Inc. INVA | GSK PLC | 0 0.000% | -32,005,260 (Position Closed) | Filing History |
| 2021-05-03 5:19 pm Purchase | 2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 44,807,844 70.600% | 7,462,050 (+19.98%) | Filing History |
| 2021-04-05 5:07 pm Sale | 2021-04-01 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 0 0.000% | -29,729,294 (Position Closed) | Filing History |
| 2021-03-17 5:17 pm Purchase | 2021-03-17 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 29,729,294 74.700% | 8,571,870 (+40.51%) | Filing History |
| 2021-02-12 5:13 pm Unchanged | 2021-02-12 | 13D | Innoviva, Inc. INVA | GSK PLC | 32,005,260 31.600% | 0 (Unchanged) | Filing History |
| 2021-02-11 09:42 am Sale | 2020-12-31 | 13G | Innoviva, Inc. INVA | Renaissance Technologies LLC | 7,881,802 7.770% | -11,895 (-0.15%) | Filing History |
| 2021-02-10 11:03 am Sale | 2020-12-31 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 6,595,483 6.500% | -211,456 (-3.11%) | Filing History |
| 2021-01-27 5:30 pm Purchase | 2021-01-26 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 21,157,424 68.000% | 3,735,824 (+21.44%) | Filing History |
| 2021-01-26 6:52 pm Sale | 2020-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 11,160,546 11.000% | -337,500 (-2.94%) | Filing History |
| 2020-12-14 08:03 am Purchase | 2020-12-11 | 13D | Innoviva, Inc. INVA | Sarissa Capital Management LP | 6,414,000 6.330% | 617,900 (+10.66%) | Filing History |
| 2020-09-01 5:28 pm Purchase | 2020-09-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 37,345,794 69.000% | 34,700,774 (+1311.93%) | Filing History |
| 2020-08-31 3:10 pm Unchanged | 2020-08-27 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 28,000,000 67.800% | 0 (Unchanged) | Filing History |
| 2020-06-12 5:30 pm Purchase | 2020-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 28,000,000 67.800% | 28,000,000 (New Position) | Filing History |
| 2020-04-23 5:00 pm Purchase | 2020-04-22 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 2,645,020 19.996% | 2,645,020 (New Position) | Filing History |